Telix Pharmaceuticals Limited (ASX:TLX)
Australia
· Delayed Price · Currency is AUD 14.85
-0.53 (-3.45%)
Sep 26, 2025, 4:14 PM AEST
Telix Pharmaceuticals Market Cap
Telix Pharmaceuticals has a market cap or net worth of 5.03 billion as of September 26, 2025. Its market cap has decreased by -15.73% in one year.
Market Cap
5.03B
Enterprise Value
5.35B
Revenue
1.01B
Ranking
n/a
PE Ratio
228.33
Stock Price
14.85
Market Cap Chart
Since November 15, 2017, Telix Pharmaceuticals's market cap has increased from 152.03M to 5.03B, an increase of 3,205.49%. That is a compound annual growth rate of 55.98%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 93.96B |
| Pro Medicus | 31.54B |
| Cochlear | 18.31B |
| Sonic Healthcare | 10.45B |
| Ramsay Health Care | 7.31B |
| Ansell | 4.57B |
| Mesoblast | 3.07B |
| Neuren Pharmaceuticals | 2.45B |